This week's IL newsletter: Weight loss jabs – Access remains deeply unequal, yet public interest in Mounjaro, Wegovy and Ozempic is soaring. #WeightLossJabs #NHSAccess #HealthInequality #DisabilityAndHealth #IndependentLiving #ILnews
buff.ly/Kd9OqDF
0
0
0
0